JenniferSoungMD

Dermatology • Santa Ana, CA

Director of Clinical Research, Southern California Dermatology, Inc.

Join to view full profile

Dr. Soung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Soung's full profile

Already have an account?

Office
1125 East 17th St, Suite West 244-248
Santa Ana, CA 92701
Phone+1 714-547-5151

Education & Training

University of California (Irvine)Residency, Dermatology, 2007 - 2010
Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2007 - 2010
UCLA-VA Greater Los AngelesInternship, Internal Medicine, 2005 - 2006
Albert Einstein College of MedicineClass of 2005

Certifications & Licensure

CA State Medical License 2008 - 2025
NY State Medical License 2006 - 2009
American Board of Dermatology Dermatology

Clinical Trials

Evaluation of Vitamin D Levels in Psoriasis Patients Start of enrollment: 2013 Jun 01
Withdrawn
A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris Start of enrollment: 2014 Apr 01
Completed
Phase 2
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) Start of enrollment: 2016 Jan 21
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital Psoriasis Start of enrollment: 2016 Apr 01
Completed
Phase 3
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Lebrikizumab monotherapy impacts on quality of life scores through improved itch and sleep interference in two Phase 3 trials.
Jennifer Soung, Sonja Ständer, Jan Gutermuth, Ignasi Pau-Charles, Zach Dawson
The Journal of Dermatological Treatment. 2024-12-01
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis an...
Warren A James, Angela L Rosenberg, Jashin J Wu, Sylvia Hsu, April Armstrong
Journal of the American Academy of Dermatology. 2024-08-01
1 citations
The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis.
Jennifer Soung, Vivian Laquer, Joseph F Merola, Angela Moore, Hany Elmaraghy
Dermatology and Therapy. 2024-08-01

Press Mentions

Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque PsoriasisMarch 23rd, 2023
How Health Care Worker Dissatisfaction Is Fueling a New Trend in Health CareDecember 24th, 2022
Practical Pearls Guide Treatment of Psoriasis in Tricky AreasNovember 9th, 2022
Join now to see all